Zoetis (ZTS) Profit Margin History

Historical gross, operating and net quarterly profit margin for Zoetis (ZTS) over the last 10 years. The current net profit margin for Zoetis as of May 25, 2018 is 17.97%.

Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $41.008B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.